-
COST COMPARISON OF ATEZOLIZUMAB IN CANADA FOR THE FIRST-LINE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS WITH HIGH PROGRAMMED DEATH-LIGAND 1 EXPRESSION
Mar 18, 2026, 21:38 PM -
TEMPORAL TRENDS AND DETERMINANTS OF AORTIC VALVE REPLACEMENT IN PATIENTS WITH ASYMPTOMATIC SEVERE AORTIC STENOSIS
Mar 18, 2026, 21:38 PM -
USE OF REAL-WORLD EVIDENCE ON US BRANDED HCP DRUG WEBSITES: AN AI-ENABLED CONTENT ANALYSIS
Mar 18, 2026, 21:38 PM -
PROJECT ORBIS: DOES REGULATORY ACCELERATION TRANSLATE TO FASTER GLOBAL PATIENT ACCESS?
Mar 18, 2026, 21:38 PM -
COMPARISON OF SAMPLING STRATEGIES TO ADDRESS SEVERE DATA IMBALANCE AND COMPUTATIONAL BENCHMARKING FOR TIME-TO-EVENT PREDICTIVE MODEL DEVELOPMENT ACROSS LOCAL AND HIGH-PERFORMANCE COMPUTING ENVIRONMENTS: PREDICTION OF ALCOHOL USE DISORDER AND OPIOID...
Mar 18, 2026, 21:38 PM -
WHEN ADHERENCE ESTIMATES DIFFER: THE IMPACT OF DATA SOURCE AND GAP HANDLING IN REAL-WORLD MEDICATION USE ASSESSMENT
Mar 18, 2026, 21:38 PM -
ESTIMATINGTHE EFFECTS OF VARIED VACCINATION COVERAGE LEVELS ON A MEASLES OUTBREAK IN AN ISOLATED POPULATION
Mar 18, 2026, 21:38 PM -
COMPARING INFECTION OUTCOMES AND ANTIBIOTIC USE IN ADMINISTRATIVE CLAIMS FOLLOWING CYSTOURETHROSCOPY WITH SINGLE USE VERSUS REUSABLE SCOPES
Mar 18, 2026, 21:38 PM -
TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH LOCALIZED PROSTATE CANCER TREATED WITH EXTERNAL BEAM RADIATION THERAPY
Mar 18, 2026, 21:38 PM -
PATTERNS OF BREAST CANCER SCREENING UTILIZATION IN BRAZIL’S PRIVATE HEALTH SECTOR: AN ARTIFICIAL INTELLIGENCE ANALYSIS, 2014-2023
Mar 18, 2026, 21:38 PM -
ANALYSIS OF GENE THERAPIES AUTHORIZED BY HEALTH CANADA, AND COMPARISON WITH THE U.S. FOOD AND DRUG ADMINISTRATION, AND THE EUROPEAN MEDICINES AGENCY
Mar 18, 2026, 21:38 PM -
REAL-WORLD DATA IN DEMENTIA RESEARCH: IMPLICATIONS FOR HEALTH ECONOMICS AND OUTCOMES RESEARCH
Mar 18, 2026, 21:38 PM -
WHEN TRIALS FALL SHORT: LEVERAGING REAL-WORLD EVIDENCE TO ADVANCE PRECISION THERAPIES
Mar 18, 2026, 21:38 PM -
EFFECT OF MENTAL HEALTH PARITY AND ADDICTION EQUITY ACT (MHPAEA) ON MENTAL HEALTH CARE UTILIZATION
Mar 18, 2026, 21:38 PM -
REAL-WORLD COMPARISON OF OLANZAPINE/SAMIDORPHAN VS OLANZAPINE: AN ASSESSMENT OF TREATMENT PATTERNS AND ACUTE CARE EVENTS AMONG PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER
Mar 18, 2026, 21:38 PM -
REAL-WORLD USE OF GENERATIVE AI ASSISTANT TOOLS ACROSS HEALTH ECONOMICS AND OUTCOMES RESEARCH WORKFLOWS: A SCOPING REVIEW
Mar 18, 2026, 21:38 PM -
COST SAVINGS OF AN AI-ENABLED DIGITAL TWIN PROGRAM IN PREDIABETES AND HEALTHY WEIGHT MANAGEMENT
Mar 18, 2026, 21:38 PM -
FACTORS ASSOCIATED WITH PREOPERATIVE HEALTH-RELATED QUALITY OF LIFE IN PATIENTSUNDERGOING SURGERYFOR DEGENERATIVE LUMBAR SPINE CONDITIONS: A CROSS-SECTIONAL EQ-5D STUDYIN A MULTI-ETHNIC ASIAN POPULATION
Mar 18, 2026, 21:38 PM -
LEVERAGING AI-DRIVEN NATURAL LANGUAGE PROCESSING TO ENHANCE SYMPTOM CAPTURE IN PRIMARY BILIARY CHOLANGITIS (PBC) AND PRIMARY SCLEROSING CHOLANGITIS (PSC)
Mar 18, 2026, 21:38 PM -
EVALUATING INITIAL MEDICATION ADHERENCE THRESHOLDS AS PREDICTORS OF CONTINUATION ADHERENCE AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A CLAIMS-BASED ANALYSIS
Mar 18, 2026, 21:38 PM
